IHH Healthcare has replaced Neptune Orient Lines as a constituent of the Straits Times Index (STI) following the conclusion of the half-yearly review, said the SGX.
The STI is the key benchmark for the Singapore stock market and is used as the basis of financial products including Exchange Traded Funds (ETFs), futures, warrants and other derivatives.
STI constituents account for about 60% of stock market turnover and 65% of full market capitalisation.

bid at 1.26 just bcos now it is index stock, but i think still can buy cos najib election coming
Hosay liao lah!
IHH Healthcare replaces NOL as STI constituent stock |
 
CIMB starts IHH Healthcare at outperform, target $1.53
Tags: CIMB | IHH Healthcare
WRITTEN BY DOW JONES & CO, INC
MONDAY, 03 SEPTEMBER 2012 16:31
Share this
Digg
Del.icio.us
StumbleUpon
Netscape
Yahoo
Technorati
Googlize this
Facebook
Export PDF
Print
E-mail
CIMB starts IHH Healthcare at Outperform with $1.53 target. “IHH’s extensive footprint in a defensive sector is one of the best business models around. It possesses steady-growth profile, driven by unquenchable demands for better healthcare needs. This is a direct play on the rising global healthcare costs."
It notes IHH operates an integrated healthcare business and related services, with market leadership in its three home markets of Singapore, Malaysia and Turkey as well as operations and investments in China, India, Hong Kong, Vietnam, Brunei and Macedonia.
It adds, IHH’s ability to capture the huge demand for medical travel is a big plus, with its key home markets able to act as regional hubs for medical travel. IHH’s sponsorship of the Parkway Life REIT also provides opportunities not readily available to other healthcare players, with possible further asset-recycling chances among its Malaysian assets, and with freed capital likely redeployed to growth frontiers, it says.
The stock is up 0.4% at $1.255 at 4:38 pm.
The listing of IHH has brought top-end private hospital held by Parkway Pantai bk to public market.
The real driver of the gp target long term growth is Acibadem (it recent acquired Turkish unit).
Turkey had a population of 73.6 million, which is about twice the population of both Singapore & Malaysia added together.
IHH CEO Lim target to establish Acibadem to a top end private health care provider. And is targeting on the middle class at Turkey who are willing to afford private insurance.These are the ppl when come to healthcare, they are want the best fr themselves & willing to spend.
Curently Turkey make up of 39.8% of IHH pro-forma revenue for 1Q2012. Whereas Singapore make up of: 35.5%. And Malaysia: 20.5%.
Let see how the 2Q12 they perform.
Cheers 
 
 
oic bro
isaacsgx ( Date: 26-Jul-2012 21:57) Posted:
|
Yes,i did compare to Raffles but the US and Euro Market is playing yoyo. So I decided to  take profit.
N IHH is   one of the largest listed health-care provider with market value of $9.9 billion
shadowmoon ( Date: 26-Jul-2012 20:28) Posted:
|
u clear too early bro. This one may achieve what Raffle Medical share price does.
Rem parkway medical is part of it too. How much is parkway medical previously.
Believe u know too 
isaacsgx ( Date: 26-Jul-2012 20:13) Posted:
|
very scary for IPO shares! bought in today at 1.245 and cleared at 1.26. Kopi $$ earned.
currently dow future look very green. Believe this one will grow higher tomorrow.
 
this one can easily be one that is better than Raffle medical